Cancer is not just one disease, but a large group of almost one hundred diseases. Its two main characteristics are uncontrolled growth of the cells in the human body and the ability of these cells to migrate from the original site and spread to distant sites. If the spread is not controlled, cancer can result in death.
Biomarker test shows promise for melanoma diagnosis – Biomarker test for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma, revealed by US researchers.
Plexxikon Reports Overall Survival Benefit for Melanoma Patients in PLX4032 Phase 3 Trial – Plexxikon Inc. announced positive data from an interim analysis of the BRIM3 trial, a large multi-center Phase 3 clinical study of PLX4032 (RG7204) in patients with previously untreated metastatic melanoma with the BRAF mutation.
Follow-Up Program Helps Detect Melanoma Earlier in High-Risk Patients – A follow-up program for patients at high risk of developing skin cancer appears to be associated with the detection of melanomas at early stages and with good prognosis.
MicroRNA suppresses prostate cancer stem cells and metastasis — UT MD Anderson preclinical research boosts case for new drug approach – A small slice of RNA inhibits prostate cancer metastasis by suppressing a surface protein commonly found on prostate cancer stem cells, revealed by researchers.
Behavioral therapy program reduces incontinence following radical prostatectomy – For men with incontinence for at least one year following radical prostatectomy, participation in a behavioral training program that included pelvic floor muscle training, bladder control strategies and fluid management, resulted in a significant reduction in the number of incontinence episodes.
Age plays too big a role in prostate cancer treatment decisions – Older men with high-risk prostate cancer frequently are offered fewer ? and less effective ? choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study.
Parents favor genetic testing for melanoma in their children – The vast majority of parents who tested positive for a genetic mutation that increases the risk of melanoma (the most serious form of skin cancer) support genetic testing of their children or grandchildren. Results of the two-year study at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) appear in the December issue of the journal Genetics in Medicine. The data could lead to the establishment of formal, evidence-based guidelines for genetic testing of people younger than 18 years.
FDA: Gardasil approved to prevent anal cancer – The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.
Body fat distribution associated with a higher risk of ER-negative breast cancer – Body fat distribution does not play an important role in the incidence of every subtype of premenopausal breast cancer, but is associated with an increased risk for estrogen receptor (ER)?negative breast cancer.
International clinical trial tests targeted drug for melanoma — Rush University Medical Center enrolls first US patient – Rush University Medical Center has just enrolled the first U.S. patient in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer that in its advanced stages currently has few effective treatments.
Celebrex may help prevent some non-melanoma skin cancers – New research shows the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease.
Cancer news articles may contribute to confusion about cancer – New research from North Carolina State University shows that most online news stories about cancer contain language that likely contributes to public uncertainty about the disease ? a significant finding, given that at least one-third of Americans seek health information online.
